- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.12.25 | Havas Life London unveils AI awareness campaign | ||
| 17.12.25 | AstraZeneca's Enhertu combination approved by FDA for HER2-positive breast cancer | ||
| 17.12.25 | Medicus Pharma completes patient enrolment for basal cell carcinoma trial | ||
| 16.12.25 | FDA approves first gene therapy for Wiskott-Aldrich syndrome | ||
| 16.12.25 | Researchers at University of Geneva develop test platform for cancer treatments | ||
| 15.12.25 | Lilly and Indiana University collaborate to expand clinical trial access | ||
| 15.12.25 | CGT Catapult establishes industry safety consortium for cell therapies | ||
| 12.12.25 | The trust crisis: how pharma must evolve to engage Gen Z HCPs | ||
| 12.12.25 | Lilly announces plans for $6bn US manufacture facility | ||
| 12.12.25 | Kymera reports positive results in clinical trial for atopic dermatitis | ||
| 11.12.25 | FDA launches TEMPO digital health pilot | ||
| 11.12.25 | Lilly welcomes Carolyn Bertozzi back to its Board of Directors | ||
| 11.12.25 | Setting out - why omnichannel success is about orchestration | ||
| 10.12.25 | Roche's Columvi improves survival in large B-cell lymphoma | ||
| 10.12.25 | OPEN Health appoints Diala Habib as president of two of its practices | ||
| 10.12.25 | ISPEP announces inaugural Advisory Board to strengthen global patient engagement leadership | ||
| 10.12.25 | Unlocking the full potential of healthcare company partnerships | ||
| 09.12.25 | Novo Nordisk presents new findings on semaglutide in Alzheimer's disease | ||
| 09.12.25 | Avalere Health appoints Sarah Hall as President of US Marketing | ||
| 09.12.25 | Global regulatory standards | ||
| 08.12.25 | Pfizer's Hympavzi significantly reduces bleeds in haemophilia patients | ||
| 08.12.25 | Gilead's Yescarta shows benefits for patients with large B-cell lymphoma | ||
| 08.12.25 | Patient insight: human vs AIHCPS | ||
| 05.12.25 | Bridging the affordability gap | ||
| 05.12.25 | Vandria announces positive phase 1 data for Alzheimer's treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .